It's time to admit the existence of a psychopathology of addiction

Heroin Addiction and Related Clinical Problems

Volumn 15, Issue 2, 2013, Pages 7-18

  Pani, Paolo Pier ^a   Maremmani, Angelo Giovanni Icro ^b,c   Trogu, Emanuela ^d   Ruiz, Pedro ^e   Akiskal, Hagop S ^f   Maremmani, Icro ^b,c,g  

^a Health District 8 ASL8   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c Association for the Application of Neuroscientific Knowledge to Social Aims AU CNS   (Italy)

^d Psychiatric Unit 2 ASL8   (Italy)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g G DE LISIO INSTITUTE OF BEHAVIOURAL SCIENCES   (Italy)

Author keywords

Addiction; Anxiety; Comorbidity; DSM; Impulsivity; Mood; Nosology; Psychopathology

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN;

ADDICTION; ARTICLE; BEHAVIOR CONTROL; CLINICAL FEATURE; CLINICAL INDICATOR; COMORBIDITY; DISEASE ASSOCIATION; DRUG DEPENDENCE; DSM-5; EMOTION; HUMAN; IMPULSIVENESS; MENTAL DISEASE; MOOD REGULATION; NEUROBIOLOGY; NEUROIMAGING; NEUROPATHOLOGY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUBSTANCE ABUSE;

EID: 84880161850     PISSN: 15921638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (98)

1. A.P.A. (1952): Diagnostic and Statistical Manual for Mental Disorders. American Psychiatric Association, Washington, DC.
2. A.P.A. (1968): Diagnostic and Statistical Manual of Mental Disorders, 2nd edn. American Psychiatric Association, Washington, DC.
3. A.P.A. (1987): Diagnostic and Statistical Manual of Mental Disorders, 3d ed. Revised. American Psychiatric Association, Washington,D.C.
4. A.P.A. (1994): Diagnostic and Statistical Manual of Mental Disorders, DSM-IV. American Psychiatric Association, Washington.
5. A.P.A. (2000): DSM-IV-TR. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association, Washington, DC.
6. Akiskal H. S., Akiskal K. K., Haykal R. F., Manning J. S., Connor P. D. (2005): TEMPS-A: progress towards validation of a self-rated clinical version of the Temperament Evaluation of the Memphis, Pisa, Paris, and San Diego Autoquestionnaire. J Affect Disord. 85(1-2): 3-16.
7. Akiskal H. S., Mallya G. (1987): Criteria for the 'soft' bipolar spectrum: Treatment implications. Psychopharmacol Bull. 23: 68-73.
8. Akiskal H. S., Mendlowicz M. V., Jean-Louis G., Rapaport M. H., Kelsoe J. R., Gillin J. C., Smith T. L. 2133. (2005): TEMPS-A: validation of a short version of a self-rated instrument designed to measure variations in temperament. J Affect Disord. 85(1-2): 45-52.
9. Ashley L. L., Boehlke K. K. (2012): Pathological gambling: a general overview. J Psychoactive Drugs. 44(1): 27-37.
10. Austin M. P., Dougall N., Ross M., Murray C., O'carroll R. E., Moffoot A., Ebmeier K. P., Goodwin G. M. (1992): Single photon emission tomography with 99mTcexametazime in major depression and the pattern of brain activity underlying the psychotic/neurotic continuum. J Affect Disord. 26: 31-43.
11. Baker S. C., Frith C. D., Dolan R. J. (1997): The interaction between mood and cognitive function studied with PET. Psychol Med. 27(3): 565-578.
12. Baxter L. R., Jr., Phelps M. E., Mazziotta J. C., Schwartz J. M., Gerner R. H., Selin C. E., Sumida R. M. (1985): Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. Arch Gen Psychiatry. 42: 441-447.
13. Baxter L. R., Jr., Schwartz J. M., Phelps M. E., Mazziotta J. C., Guze B. H., Selin C. E., Gerner R. H., Sumida R. M. (1989): Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry. 46: 243-250.
14. Bechara A. (2005): Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nat Neurosci. 8(11): 1458-1463.
15. Bechara A., Damasio H. (2002): Decision-making and addiction (part I): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences. Neuropsychologia. 40: 1675-1689.
16. Bechara A., Damasio H., Damasio A. R. (2003): Role of the amygdala in decision-making. Ann NY Acad Sci. 985: 356-369.
17. Bechara A., Dolan S., Hindes A. (2002): Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward? Neuropsychologia. 40(10): 1690-1705.
18. Bench C. J., Friston K. J., Brown R. G., Scott L. C., Frackowiak R. S., Dolan R. J. (1992): The anatomy of melancholia: focal abnormalities of cerebral blood fl{ligature}ow in major depression. Psychol Med. 22: 607-615.
19. Berk M., Dodd S., Kauer-Sant'anna M., Malhi G., Bourin M., Kapczinski F., Norman T. (2007): Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr Scand Suppl. 434: 41-49.
20. Berridge K. C. (2007): The debate over dopamine's role in reward: the case for incentive salience. Psychopharmacology (Berl). 191(3): 391-431.
21. Bickel W. K., Marsch L. A. (2001): Toward a behavioral economic understanding of drug dependence: delay discounting processes. Addiction. 96: 73-86.
22. Blum K., Braverman E. R., Holder J. M., Lubar J. F., Monastra V. J., Miller D., Lubar J. O., Chen T. J., Comings D. E. (2000): Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors. J Psychoactive Drugs. 32(suppl i-iv): 1-112.
23. Blum K., Werner T., Carnes S., Carnes P., Bowirrat A., Giordano J., Oscar-Berman M., Gold M. (2012): Sex, drugs, and rock 'n' roll: hypothesizing common mesolimbic activation as a function of reward gene polymorphisms. J Psychoactive Drugs. 44(1): 38-55.
24. Blumberg H. P., Leung H. C., Skudlarski P., Lacadie C. M., Fredericks C. A., Harris B. C., Charney D. S., Gore J. C., Krystal J. H., Peterson B. S. (2003): A functional magnetic resonance imaging study of bipolar disorder: State- and trait-related dysfunction in ventral prefrontal cortices. Arch Gen Psychiatry. 60: 601-609.
25. Blumberg H. P., Stern E., Ricketts S., Martinez D., De Asis J., White T., Epstein J., Isenberg N., Mcbride P. A., Kemperman I., Emmerich S., Dhawan V., Eidelberg D., Kocsis J. H., Silbersweig D. A. (1999): Rostral and orbital prefrontal cortex dysfunction in the manic state of bipolar disorder. Am J Psychiatry. 156: 1986-1988.
26. Brooner R. K., King V. L., Kidorf M., Schmidt C. W., George M. D., Bigelow G. E. (1997): Among treatmentseeking opioid abusers. Arch Gen Psychiatry. 54: 71-80.
27. Brown E. E., Fibiger H.C. (1993): Differential effects of excitotoxic lesions of the amygdala on cocaineinduced conditioned locomotion and conditioned place preference. Psychopharmacology (Berl). 113: 123-130.
28. Carlezon W. a. J., Konradi C. (2004): Understanding the neurobiological consequences of early exposure to psychotropic drugs: linking behavior with molecules. Neuropharmacology. 47(Suppl 1): 47-60.
29. Carlezon W. a. J., Thome J., Olson V. G., Lane-Ladd S. B., Brodkin E. S., Hiroi N., Duman R. S., Neve R. L., Nestler E. J. (1998): Regulation of cocaine reward by CREB. Science. 282(5397): 2272-2275.
30. Chartoff E. H., Papadopoulou M., Macdonald M. L., Parsegian A., Potter D., Konradi C., Carlezon W. A., Jr. (2009): Desipramine reduces stress-activated dynorphin expression and CREB phosphorylation in NAc tissue. Mol Pharmacol. 75(3): 704-712.
31. Childress A.R., Mozley P. D., Mcelgin W., Fitzgerald J., Reivich M., O'brien C.P. (1999): Limbic activation during cue-induced cocaine craving. Am J Psychiatry. 156: 11-18.
32. Di Chiara G. (2002): Nucleus accumbens shell and core dopamine: differential role in behavior and addiction. Behav Brain Res. 137(1-2): 75-114.
33. Di Chiara G., Imperato A. (1988): Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A. 85(14): 5274-5378.
34. Dougherty D. D., Bona A. A., Spencer T. J., Rauch S. L., Madras B. K., Fischman A. J. (1999): Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet. 354(9196): 2132-2133.
35. Drevets W. C. (2007): Orbitofrontal Cortex Function and Structure in Depression. Ann NY Acad Sci. 1121: 499-527.
36. Drevets W. C., Gautier C., Price J. C., Kupfer D. J., Kinahan P. E., Grace A. A., Price J. L., Mathis C. A. (2001): Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol Psychiatry. 49(2): 81-96.
37. Drevets W. C., Kishore M. G., Krishnan R. K. R. (1999): Neuroimaging studies of mood disorders. In: Charney D. S., Nestler E. J., Bunney B. S. (Eds.): Neurobiology of mental illness. Oxford University Press, New York. pp.
38. Drevets W. C., Videen T. O., Price J. L., Preskorn S. H., Carmichael S. T., Raichle M. E. (1992): A functional anatomical study of unipolar depression. J Neurosci. 12: 3628-3641.
39. Edwards G., Gross M. M. (1976): Alcohol dependence: provisional description of a clinical syndrome. Br Med J. 1: 1058-1061.
40. Elliott R., Ogilvie A., Rubinsztein J. S., Calderon G., Dolan R. J., Sahakian B. J. (2004): Abnormal ventral frontal response during performance of an affective go/ no go task in patients with mania. Biol Psychiatry. 55: 1163-1170.
41. Elman I., Breiter H. C., Gollub R. L., Krause S., Kantor H. L., Baumgartner W. A., Gastfriend D. R., Rosen B. R. (1999): Depressive symptomatology and cocaineinduced pituitary-adrenal axis activation in individuals with cocaine dependence. Drug Alcohol Depend. 56(1): 39-45.
42. Fillmore M. T., Rush C. R. (2002): Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend. 66: 265-273.
43. Franklin T. R., Druhan J. P. (2000): Expression of Fos-related antigens in the nucleus accumbens and associated regions following exposure to a cocainepaired environment. Eur J Neurosci. 12: 2097-2106.
44. Garavan H., Pankiewicz J., Bloom A., Cho J.K., Sperry L., Ross T.J., Salmeron B.J., Risinger R., Kelley D., Stein E. A. (2000): Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry. 157(11): 1789-1798.
45. George M. S., Ketter T. A., Parekh P. I., Rosinsky N., Ring H. A., Pazzaglia P. J., Marangell L. B., Callahan A. M., Post R. M. (1997): Blunted left cingulate activation in mood disorder subjects during a response interference task (the Stroop). J Neuropsychiatry Clin Neurosci. 9(1): 55-63.
46. Gerra G., Angioni L., Zaimovic A., Moi G., Bussandri M., Bertacca S., Santoro G., Gardini S., Caccavari R., Nicoli M. A. (2004): Substance use among high-school students: relationships with temperament, personality traits, and parental care perception. Subst Use Misuse. 39(2): 345-367.
47. Hasin D., Samet S., Nunes E., Meydan J., Matseoane K., Waxman R. (2006): Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am J Psychiatry. 163(4): 689-696.
48. Hollerman J. R., Schultz W. (1998): Dopamine neurons report an error in the temporal prediction of reward during learning. Nat Neurosci. 1: 304-309.
49. Kalivas P. W., Volkow N. D. (2005): The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 162: 1403-1413.
50. Kessler R. C., Mcgonagle K. A., Zhao S., Nelson C. B., Hughes M., Eshleman S., Wittchen H.-U., Kendler K. S. (1994): Lifetime and 12-month prevalence of DSM-IIIR psychiatric disorders in the United States:results from the National Comorbidity Survey. Arch Gen Psychiatry. 51: 8-19.
51. Kessler R. C., Nelson C. B., Mcgonagle K. A., Edlund M. J., Frank R. G., Leaf P. J. (1996): The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry. 66(1): 17-31.
52. Khantzian E. J., Treece C. (1985): DSM-III psychiatric diagnosis of narcotic addicts: Recent findings. Arch Gen Psychiatry. 42: 1067-1077.
53. Kirby K. N., Petry N. M., Bickel W. K. (1999): Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen. 128(1): 78-87.
54. Koob G. F., Bloom F. E. (1988): Cellular and molecular mechanisms of drug dependence. Science. 242: 715-723.
55. Kronhaus D. M., Lawrence N. S., Williams A. M., Frangou S., Brammer M. J., Williams S. C., Andrew C. M., Phillips M. L. (2006): Stroop performance in bipolar disorder: further evidence for abnormalities in the ventral prefrontal cortex. Bipolar Disord. 8(1): 28-39.
56. Maas L. C., Lukas S. E., Kaufman M. J., Weiss R. D., Daniels S. L., Rogers V. W., Kukes T. J., Renshaw P. F. (1998): Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. Am J Psychiatry. 155: 124-126.
57. Madden G. J., Petry N. M., Badger G. J., Bickel W. K. (1997): Impulsive and self control choices in opioid dependent patients and non-drug-using control participants: drug and monetary rewards. Exp Clin Psychopharmacol. 5: 256-262.
58. Maremmani A. G. I., Rovai L., Pani P. P., Pacini M., Lamanna F., Rugani F., Schiavi E., Dell'osso L., Maremmani I. (2011): Do methadone and buprenorphine have the same impact on psychopathological symptoms of heroin addicts? Ann Gen Psychiatry. 10:17.
59. Maremmani I., Pacini M., Lubrano S., Lovrecic M., Perugi G. (2003): Dual diagnosis heroin addicts. The clinical and therapeutic aspects. Heroin Addict Relat Clin Probl. 5(2): 7-98.
60. Maremmani I., Pacini M., Pani P. P., Perugi G., Deltito J., Akiskal H. (2007): The mental status of 1090 heroin addicts at entry into treatment: should depression be considered a 'dual diagnosis'? Ann Gen Psychiatry. 6: 31.
61. Maremmani I., Pani P. P., Pacini M., Bizzarri J. V., Trogu E., Maremmani A. G. I., Perugi G., Gerra G., Dell'osso L. (2010): Subtyping Patients with Heroin Addiction at Treatment Entry: Factors Derived fron the SCL-90. Ann Gen Psychiatry. 9(1): 15.
62. Mayberg H. S. (1994): Frontal lobe dysfunction in secondary depression. J Neuropsychiatry Clin Neurosci. 6: 428-442.
63. Mcclure S. M., Laibson D. I., Loewenstein G., Cohen J. D. (2004): Separate neural systems value immediate and delayed monetary rewards. Science. 306(5695): 503-507.
64. Meil W. M., See R. E. (1997): Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from selfadministered cocaine. Behav Brain Res. 87: 139-148.
65. Merikangas K. R., Mehta R. L., Molnar B. E., Walters E. E., Swendsen J. D., Aguilar-Gaziola S., Bijl R., Borges G., Caraveo-Anduaga J. J., Dewit D. J., Kolody B., Vega W. A., Wittchen H. U., Kessler R. C. (1998): Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict Behav. 23(6): 893-907.
66. Migliorelli R., Starkstein S. E., Teson A., De Quiros G., Vazquez S., Leiguarda R., Robinson R. G. (1993): SPECT findings in patients with primary mania. J Neuropsychiatry Clin Neurosci. 5: 379-383.
67. Milby J. B., Sims M. K., Khuder S., Schumacher J. E., Huggins N., Mclellan A. T., Woody G., Haas N. (1996): Psychiatric comorbidity: prevalence in methadone maintenance treatment. Am J Drug Alcohol Abuse. 22(1): 95-107.
68. Nemeroff C. B. (1992): New vistas in neuropeptide research in neuropsychiatry: focus on corticotropinreleasing factor. Neuropsychopharmacology. 6: 69-75.
69. Nestler E. J. (2002): Common molecular and cellular substrates of addiction and memory. Neurobiol Learn Mem. 78(3): 637-647.
70. Nestler E. J. (2004): Historical review: molecular and cellular mechanisms of opiate and cocaine addiction. Trends Pharmacol Sci. 25: 210-218.
71. Nunes E. V., Rounsaville B. J. (2006): Comorbidity of substance use with depression and other mental disorders: from Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) to DSM-V. Addiction. 101(suppl 1): 89-96.
72. Pani P. P., Maremmani I., Pacini M., Lamanna F., Maremmani A. G. I., Dell'osso L. (2011): Effect of psychiatric severity on the outcome of methadone maintenance treatment. Eur Addict Res. 17(2): 80-89.
73. Pani P. P., Maremmani I., Trogu E., Gessa G. L., Ruiz P., Akiskal H. S. (2010): Delineating the psychic structure of substance abuse and addictions: Should anxiety, mood and impulse-control dysregulation be included? J Affect Disord. 122: 185-197.
74. Perugi G., Frare F., Madaro D., Maremmani I., Akiskal H. S. (2002): Alcohol abuse in social phobic patients: is there a bipolar connection? J Affect Disord. 68(1): 33-39.
75. Petry N. M. (2001): Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls. Psychopharmacology. 154: 243-250.
76. Petry N. M. (2003): Discounting of money, health, and freedom in substance abusers and controls. Drug Alcohol Depend. 71(2): 133-141.
77. Pietrini P., Guazzelli M., Basso G., Jaffe K., Grafman J. (2000): Neural correlates of imaginal aggressive behavior assessed by positron emission tomography in healthy subjects. Am J Psychiatry. 157(11): 1772-1781.
78. Placidi G. F., Signoretta S., Liguori A., Gervasi R., Maremmani I., Akiskal H. S. (1998): The semi-structured affective temperament interview (TEMPS-I). Reliability and psychometric properties in 1010 14-26-year old students. J Affect Disord. 47(1-3): 1-10.
79. Pontieri F. E., Tanda G., Di Chiara G. (1995): Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci U S A. 92(26): 12304-12308.
80. Raust A., Slama F., Mathieu F., Roy I., Chenu A., Koncke D., Fouques D., Jollant F., Jouvent E., Courtet P., Leboyer M., Bellivier F. (2007): Prefrontal cortex dysfunction in patients with suicidal behavior. Psychol Med. 37(3): 411-419.
81. Reynolds B., Richards J. B., Horn K., Karraker K. (2004): Delay discounting and probability discounting as related to cigarette smoking status in adults. Behav Process. 65: 35-42.
82. Robbins T. W., Everitt B. J. (2002): Limbic-striatal memory systems and drug addiction. Neurobiol Learn Mem. 8(3): 625-636.
83. Sarnyai Z., Shaham Y., Heinrichs S. C. (2001): The role of corticotropinreleasing factor in drug addiction. Pharmacol Rev. 53: 209-243.
84. Schultz W., Apicella P., Ljungberg T. (1993): Responses of monkey dopamine neurons to reward and conditioned stimuli during successive steps of learning a delayed response task. J Neurosci. 13: 900-913.
85. Sher K. J., Bartholow B. D., Wood M. D. (2000): Personality and substance use disorders: a prospective study. J Consult Clin Psychol. 68: 818-829.
86. Stam R., Bruijnzeel A. W., Wiegant V. M. (2000): Long-lasting stress sensitisation. Eur J Pharmacol. 405: 217-224.
87. Swendsen J. D., Merikangas K. R. (2000): The comorbidity of depression and substance use disorders. Clin Psychol Rev. 20(2): 173-189.
88. Volkow N. D., Fowler J. S., Wang G. J., Goldstein R. Z. (2002): Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem. 78(3): 610-624.
89. Volkow N. D., Fowler J. S., Wang G. J., Hitzemann R., Logan J., Schlyer D., Dewey S., Wolf A. P. (1993): Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse. 14: 169-177.
90. Volkow N. D., Fowler J. S., Wolf A. P., Hitzemann R., Dewey S., Bendriem B., Alpert R., Hoff A. (1991): Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry. 148: 621-626.
91. Volkow N. D., Fowler J. S., Wolf A. P., Schlyer D., Shiue C. Y., Alpert R., Dewey S. L., Logan J., Bendriem B., Christman D. (1990): Effects of chronic cocaine abuse on postsynaptic dopamine receptors. Am J Psychiatry. 147(6): 719-724.
92. Volkow N. D., Wang G. J., Fowler J. S., Hitzemann R., Angrist B., Gatley S. J., Logan J., Ding Y. S., Pappas N. (1999): Association of methylphenidate-induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction. Am J Psychiatry. 156: 19-26.
93. Volkow N. D., Wang G. J., Telang F., Fowler J. S., Logan J., Jayne M., Ma Y., Pradhan K., Wong C. (2007): Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci. 27(46): 12700-12706.
94. Vuchinich R. E., Simpson C. A. (1998): Hyperbolic temporal discounting in social drinkers and problem drinkers. Exp Clin Psychopharmacol. 6: 292-305.
95. Wang G. J., Volkow N. D., Fowler J. S., Cervany P., Hitzemann R. J., Pappas N. R., Wong C. T., Felder C. (1999): Regional brain metabolic activation during craving elicited by recall of previous drug experiences. Life Sci. 64: 775-784.
96. Weiss F., Ciccocioppo R., Parsons L. H., Katner S., Liu X., Zorrilla E. P., Valdez G. R., Ben Shahar O., Angeletti S., Richter R. R. (2001): Compulsive drugseeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann NY Acad Sci. 937: 1-26.
97. Wexler B. E., Gottschalk C.H., Fulbright R. K., Prohovnik I., Lacadie C. M., Rounsaville B. J., Gore J. C. (2001): Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry. 158: 86-95.
98. Yucel M., Lubman D. I. (2007): Neurocognitive and neuroimaging evidence of behavioural dysregulation in human drug addiction: implications for diagnosis, treatment and prevention. Drug Alcohol Rev. 26(1): 33-39.